3 recruiting, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Recruiting 1 |
Follow Direct Oral Anticoagulants (DOACs): new trials by email Literature Review of Direct Oral Anticoagulants (DOACs) trials Research Report on Direct Oral Anticoagulants (DOACs)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs) Direct Oral Anticoagulants (DOACs), Oral Surgical Procedures | Recruiting | University of Pisa | 100 | 2026-04-01 | 2026-04-09 | |
| Effect of Apiban Therapy on AVF Maturation in ESRD Patients Apixaban - Endstage Renal Disease, Direct Oral Anticoagulants (DOACs) | Not applicable | Recruiting | Combined military hospital lahore | 190 | 2026-01-01 | 2026-05-07 |
| SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye) Medication Adherence, Atrial Fibrillation (AF) | Enrolling by invitation | Kotyora Family Medicine Health Management and Education Association | 1000 | 2025-12-15 | 2026-02-25 | |
| Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs Blood Transfusion, Hip Fracture Surgeries | Recruiting | St. Antonius Hospital | 374 | 2025-11-01 | 2025-12-30 | |
| OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs "non-high risk" thrombotic APS patients treated with DOAC - Antiphospholipid Syndrome (APS), Direct Oral Anticoagulants (DOACs) | Not yet recruiting | Central Hospital, Nancy, France | 500 | 2025-07-01 | 2025-04-20 | |
| LED Application Following Dental Extraction in Patients Taking Direct Oral Anticoagulants. LED light - Direct Oral Anticoagulants (DOACs) | Not applicable | Active not recruiting | University College, London | 50 | 2023-08-17 | 2025-05-14 |
| Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur Femoral fracture surgery - Direct Oral Anticoagulants (DOACs), Femoral Fractures | Completed | Centre Hospitalier Universitaire de Nīmes | 610 | 2022-01-01 | 2026-01-23 |
Antiphospholipid Syndrome (1) · Arteriovenous Fistula (1) · Atrial Fibrillation (1) · Femoral Fractures (1) · Hemorrhage (1) · Hip Fractures (1) · Medication Adherence (1) · Transfusion Reaction (1)
Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (2) · Fractures, Bone (2) · Immune System Diseases (2) · Leg Injuries (2) · Pathologic Processes (2) · Wounds and Injuries (2) · Arrhythmias, Cardiac (1) · Arteriovenous Malformations (1) · Autoimmune Diseases (1) · Behavior (1) · Cardiovascular Abnormalities (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Femoral Fractures (1)
Anticoagulants (1) · N(4)-oleylcytosine arabinoside (1) · apixaban (1)
Central Hospital, Nancy, France (1) · Centre Hospitalier Universitaire de Nīmes (1) · Combined military hospital lahore (1) · Kotyora Family Medicine Health Management and Education Association (1) · St. Antonius Hospital (1) · University College, London (1) · University of Pisa (1)
France (1) · Italy (1) · Netherlands (1) · Pakistan (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Henk Jan Schuijt, MD, PhD (1) · Muhammad Irfan Khan, Vascular Sur (1) · Philippe Cuvillon (1)